Two people have been rescued alive in Nepal nine days after a flash flood killed more than 1,200 people.
READ MORE'Ultimately, he sacrificed his life for our cause. His service was brief but he blazed the brightest star.
'It ripped part of my calf off.'
Quantinuum Unveils Generative Quantum AI Framework that Harnesses Unique Quantum-Generated Data to Tackle Complex Problems Impossible for Classical Computing
ADELAIDE,Australia,Feb. 5,2025--University of Adelaide Associate Professor Jiawen Li has been awarded a prestigious global award by tech giant Sony and scientific publishing company Nature,for her wor
LONDON,Feb. 5,2025-- The Fintech industry continues to thrive,driving innovation and reshaping global finance. At the forefront of this revolution is Breinrock,a rising star in the financial technolo
SINGAPORE,Feb. 5,2025-- Asia is the region most impacted by lung cancer,accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung cancer deaths worldwide(1).
JAKARTA,Indonesia,Feb. 5,2025-- PT Medco Energi Internasional Tbk (MedcoEnergi) has received an upgrade to its MSCI ESG rating,from "A" to "AA". This recognition positions MedcoEne
TASHKENT,Uzbekistan,Jan. 24,2025-- Sungrow,the global leading PV inverter and energy storage system (ESS) provider,in partnership with China Energy Engineering Corporation (CEEC),areproud to announce
SHANGHAI,Feb. 5,2025-- In the field of biopharmaceuticals,every technological innovation has the potential to revolutionize treatment strategies.Sanyou Bio\'s Intelligent Hundred-Trillion Molecule Lib
SINGAPORE,Feb. 5,2025-- The KOREA INNOVATION FOUNDATION (INNOPOLIS) participated in Asia\'s largest deep-tech event \'SWITCH 2024\' held at Marina Bay Sands in Singapore from the 27th to the 30th and
Effective as of February 10,2025 Becomes member of Ericsson\'s Executive Team,reporting to the CEO STOCKHOLM,Feb. 5,2025-- Ericsson (NASDAQ: ERIC) today announces the appointment of Charlotte Levert a
ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity,supporting
© OfficialAffairs
